Lapeer · Rochester Hills · Telehealth
Cervical Dysplasia
(CIN)
CIN 1, CIN 2, CIN 3 — What Each Grade Means and How Each Is Managed
Cervical intraepithelial neoplasia — CIN — is the histologic diagnosis given to precancerous changes in cervical cells identified on biopsy. Not all CIN is treated the same way. The grade of CIN determines whether it is observed, treated, or treated urgently, and understanding the difference gives you the context to engage with your clinical management plan.
Dr. Ramona D. Andrei, MD, PhD, FACOG manages cervical dysplasia including LEEP procedures at both our Lapeer and Rochester Hills offices.
Board-certified gynecology & minimally invasive surgery · Most major insurances accepted
Serving Lapeer County & Oakland County
Cervical intraepithelial neoplasia (CIN) is classified into three grades based on what proportion of the cervical epithelium is replaced by abnormal cells. This grading reflects the degree of dysplasia and directly determines the management pathway. CIN is precancerous change — it is not cancer. Its clinical importance is that higher-grade CIN, if untreated, carries a meaningful probability of progressing to invasive cervical cancer over years to decades. Lower-grade CIN frequently regresses spontaneously without intervention.
CIN 1 — Mild Dysplasia
CIN 1 means that abnormal cells occupy the lower one-third of the cervical epithelium. It corresponds to LSIL on cytology. CIN 1 most commonly reflects active HPV infection rather than true progressive dysplasia and regresses spontaneously in approximately 60 percent of cases within two years. Current guidelines do not recommend treatment of CIN 1 because the risk of regression exceeds the risk of progression and treatment carries its own small risks. Management of CIN 1 is surveillance: co-testing at 12 months, and again at 24 months if still positive. Treatment is considered only for CIN 1 that persists for two years or longer without regression.
CIN 2 — Moderate Dysplasia
CIN 2 means abnormal cells occupy the lower two-thirds of the cervical epithelium. It is the threshold at which treatment is typically recommended because the balance between regression and progression tilts meaningfully: approximately 40 to 50 percent of CIN 2 regresses spontaneously, but 20 percent or more can progress to CIN 3 or worse without treatment. In women under 25 and women who are pregnant, observation with close surveillance may be preferred over treatment given that progression risk in these groups is lower and treatment carries cervical implications for future pregnancies. For most women, CIN 2 is treated with LEEP. Learn about LEEP →
CIN 3 — Severe Dysplasia / Carcinoma In Situ
CIN 3 means abnormal cells occupy more than two-thirds of the cervical epithelium — the full thickness in the most severe cases (carcinoma in situ). CIN 3 is the highest grade of cervical intraepithelial neoplasia and has a significant risk of progression to invasive cervical cancer if untreated — estimated at 30 to 50 percent over 30 years in studies of untreated women. Treatment is uniformly recommended. LEEP is the standard treatment for most CIN 3. Cold knife conization is used when LEEP is not technically adequate, when margins need to be evaluated more carefully, or when the lesion extends into the endocervical canal. LEEP → | Cold knife conization →
After Treatment — Post-Procedure Surveillance
Treatment with LEEP or conization is highly effective at removing CIN 2 and CIN 3, with success rates above 90 percent for clear margins. However, post-treatment surveillance is important because residual or recurrent dysplasia can occur. Current guidelines recommend co-testing at 6 months after treatment, then annually for two to three years, before returning to routine screening intervals. Post-treatment surveillance is managed at Lapeer Women’s Health as part of the continuity of cervical health care.
Our team at Lapeer Women’s Health provides complete CIN management at both our Lapeer and Rochester Hills offices. No referral required.
Schedule a Gynecologic VisitEducational purposes only. Not medical advice. Content reviewed by Dr. Ramona D. Andrei, MD PhD FACOG.
Gynecologic care for women of every age
Lapeer Women’s Health — Rochester Hills
2710 S Rochester Rd, Suite 2
Rochester Hills, MI 48307
Serving patients in Lapeer, Rochester Hills, and surrounding communities throughout Southeast Michigan.